IMGN Historical PE Ratio image   This IMGN PE ratio history page last updated 5/9/2022
IMGN Historical PE Ratio Chart
Data adjusted for IMGN split history

PeriodPriceGAAPAnnualizedPE
Q1 2022
5/6/2022
4.63-0.10-0.40NA
Q4 2021
2/25/2022
5.49-0.17-0.68NA
Q3 2021
10/29/2021
6.03-0.18-0.72NA
Q2 2021
7/30/2021
5.61-0.15-0.60NA
Q1 2021
5/10/2021
6.51-0.17-0.68NA
Q4 2020
2/12/2021
10.530.160.6416.5
Q3 2020
11/6/2020
6.08-0.13-0.52NA
Q2 2020
7/31/2020
4.11-0.14-0.56NA
Q1 2020
5/1/2020
3.75-0.17-0.68NA
Q4 2019
2/14/2020
6.800.030.1256.7
Q3 2019
11/1/2019
3.04-0.15-0.60NA
Q2 2019
8/2/2019
2.24-0.29-1.16NA
Q1 2019
5/3/2019
2.88-0.30-1.20NA
Q4 2018
2/8/2019
5.67-0.28-1.12NA
Q3 2018
11/2/2018
5.67-0.32-1.28NA
Q2 2018
7/27/2018
9.80-0.31-1.24NA
Q1 2018
5/4/2018
10.57-0.30-1.20NA
Q4 2017
2/9/2018
8.91-0.11-0.44NA
Q3 2017
11/3/2017
5.63-0.37-1.48NA
Q2 2017
2/17/2017
2.43-0.39-1.56NA
Q1 2017
10/28/2016
1.92-0.51-2.04NA
Q4 2016
8/4/2016
2.86-0.51-2.04NA
Q3 2016
4/29/2016
6.85-0.37-1.48NA
Q2 2016
1/29/2016
8.49-0.38-1.52NA
Q1 2016
10/27/2015
11.32-0.39-1.56NA
Q4 2015
7/31/2015
18.02-0.35-1.40NA
Q3 2015
4/24/2015
9.96-0.25-1.00NA
Q2 2015
1/30/2015
7.630.160.6411.9
Q1 2015
10/24/2014
8.75-0.26-1.04NA
Q4 2014
8/1/2014
10.47-0.31-1.24NA
Q3 2014
4/25/2014
12.39-0.44-1.76NA
Q2 2014
1/31/2014
14.990.040.1693.7
Q1 2014
10/25/2013
17.68-0.13-0.52NA
Q4 2013
8/2/2013
18.93-0.26-1.04NA
Q3 2013
4/26/2013
16.31-0.02-0.08NA
Q2 2013
1/25/2013
15.04-0.29-1.16NA
Q1 2013
10/26/2012
11.47-0.30-1.20NA
Q4 2012
8/3/2012
13.90-0.29-1.16NA
Q3 2012
4/27/2012
12.89-0.24-0.96NA
Q2 2012
1/27/2012
13.83-0.16-0.64NA
Q1 2012
10/27/2011
14.44-0.26-1.04NA
IMGN PE History Chart
PeriodPriceGAAPTTMPE
Q1 2022
5/6/2022
4.63-0.10-0.60NA
Q4 2021
2/25/2022
5.49-0.17-0.67NA
Q3 2021
10/29/2021
6.03-0.18-0.34NA
Q2 2021
7/30/2021
5.61-0.15-0.29NA
Q1 2021
5/10/2021
6.51-0.17-0.28NA
Q4 2020
2/12/2021
10.530.16-0.28NA
Q3 2020
11/6/2020
6.08-0.13-0.41NA
Q2 2020
7/31/2020
4.11-0.14-0.43NA
Q1 2020
5/1/2020
3.75-0.17-0.58NA
Q4 2019
2/14/2020
6.800.03-0.71NA
Q3 2019
11/1/2019
3.04-0.15-1.02NA
Q2 2019
8/2/2019
2.24-0.29-1.19NA
Q1 2019
5/3/2019
2.88-0.30-1.21NA
Q4 2018
2/8/2019
5.67-0.28-1.21NA
Q3 2018
11/2/2018
5.67-0.32-1.04NA
Q2 2018
7/27/2018
9.80-0.31-1.09NA
Q1 2018
5/4/2018
10.57-0.30-1.17NA
Q4 2017
2/9/2018
8.91-0.11-1.38NA
Q3 2017
11/3/2017
5.63-0.37-1.78NA
Q2 2017
2/17/2017
2.43-0.39-1.78NA
Q1 2017
10/28/2016
1.92-0.51-1.77NA
Q4 2016
8/4/2016
2.86-0.51-1.65NA
Q3 2016
4/29/2016
6.85-0.37-1.49NA
Q2 2016
1/29/2016
8.49-0.38-1.37NA
Q1 2016
10/27/2015
11.32-0.39-0.83NA
Q4 2015
7/31/2015
18.02-0.35-0.70NA
Q3 2015
4/24/2015
9.96-0.25-0.66NA
Q2 2015
1/30/2015
7.630.16-0.85NA
Q1 2015
10/24/2014
8.75-0.26-0.97NA
Q4 2014
8/1/2014
10.47-0.31-0.84NA
Q3 2014
4/25/2014
12.39-0.44-0.79NA
Q2 2014
1/31/2014
14.990.04-0.37NA
Q1 2014
10/25/2013
17.68-0.13-0.70NA
Q4 2013
8/2/2013
18.93-0.26-0.87NA
Q3 2013
4/26/2013
16.31-0.02-0.90NA
Q2 2013
1/25/2013
15.04-0.29-1.12NA
Q1 2013
10/26/2012
11.47-0.30-0.99NA
Q4 2012
8/3/2012
13.90-0.29-0.95NA
Q3 2012
4/27/2012
12.89-0.24NANA
Q2 2012
1/27/2012
13.83-0.16NANA
Q1 2012
10/27/2011
14.44-0.26NANA
Quotes delayed 20 minutes

Email EnvelopeFree IMGN Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Immunogen (IMGN) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

IMGO PE Ratio History
IMNM PE Ratio History
IMPL PE Ratio History
IMRA PE Ratio History
IMRX PE Ratio History
IMUX PE Ratio History
IMVT PE Ratio History
INAB PE Ratio History
INBX PE Ratio History
INCY PE Ratio History
How should the IMGN historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?

✔️Accepted answer: There are a number of different approaches when it comes to calculating a historical PE ratio for a company like Immunogen. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this IMGN Historical PE Ratio page.

What is the average historical PE for IMGN based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?

✔️Accepted answer: The IMGN historical PE ratio using the annualized quarterly earnings method works out to 44.7.

What is the average historical PE for IMGN based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?

✔️Accepted answer: The IMGN historical PE ratio using the TTM earnings method works out to NA.

On this page we presented the IMGN Historical PE Ratio information for Immunogen' stock. The average IMGN historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 44.7. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average IMGN historical PE based on this TTM earnings result method is NA. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this IMGN historical PE result, against the recent PE: when this page was posted on 5/6/2022, the most recent closing price for IMGN had been 4.63, and the most recent quarterly earnings result, annualized, was 0.64. Meanwhile, the most recent TTM earnings summed to NA. From these numbers, we calculate the recent IMGN PE on 5/6/2022 based on annualized quarterly EPS was 7.2. Based on IMGN's history, that recent PE is low relative to the historical average, with the recent PE 83.9% lower than the historical average PE across our data set for Immunogen.

For self directed investors doing their due diligence on IMGN or any other given stock, valuation analysis for IMGN can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Immunogen PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for IMGN. Thanks for visiting, and the next time you need to research IMGN Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.

Recommended: Funds Holding PRXI, RLAY Insider Buying, Funds Holding OMGA.

 

IMGN Historical PE Ratio | www.HistoricalPERatio.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.